Polifka I, Agaimy A, Moch H, Hartmann A
Pathologisches Institut, Universitätsklinikum Erlangen, Krankenhausstr. 8-10, 91054, Erlangen, Deutschland.
Department für Pathologie und Molekularpathologie, Universitätsspital Zürich, Zürich, Schweiz.
Pathologe. 2021 May;42(3):294-304. doi: 10.1007/s00292-021-00937-6. Epub 2021 Apr 6.
The classification of renal cell carcinoma (RCC) has changed remarkably in recent years.
This is a short overview of the classification of RCC, focusing on new developments.
A literature search was performed resulting in an overview of the classification of RCC. Emerging entities were discussed in detail.
Apart from the RCC subtypes in the WHO classification of 2016, several emerging entities came up over the last few years that are characterized by typical morphology, immunophenotype, and especially specific genetic alterations.
Precise classification of RCC is the key to better prognostic assessment with potential tumor-specific therapy and plays an important role in the recognition of possible association with hereditary tumor syndromes.
近年来,肾细胞癌(RCC)的分类发生了显著变化。
本文简要概述RCC的分类,重点关注新进展。
进行文献检索,以综述RCC的分类。详细讨论了新出现的实体。
除了2016年世界卫生组织分类中的RCC亚型外,过去几年还出现了几个新出现的实体,其特征是典型的形态学、免疫表型,尤其是特定的基因改变。
RCC的精确分类是通过潜在的肿瘤特异性治疗进行更好预后评估的关键,并且在识别与遗传性肿瘤综合征的可能关联中发挥重要作用。